Canaccord Genuity lowers Olaplex stock price target to $1.50 on margin pressure

Olaplex (OLPX) reported its first sales growth in nine quarters for Q2 2025, with revenue up 2.3% to $106.3 million, surpassing analyst expectations and demonstrating strong gross and adjusted EBITDA margins, though it missed EPS forecasts. Despite these positive revenue trends and ongoing strategic transformation efforts, Canaccord Genuity lowered its price target to $1.50 from $2.00, maintaining a Hold rating due to anticipated near-term margin pressure from increased investments and persistent macroeconomic volatility. The stock has gained over 9% in the past week, indicating market optimism around the revenue rebound despite the cautious analyst outlook and EPS shortfall.

Analysis

Olaplex (OLPX) has demonstrated a significant operational inflection point in its Q2 2025 results, reporting its first positive sales growth in nine quarters. The 2.3% year-over-year revenue increase to $106.3 million decisively beat analyst expectations, which had forecasted declines of 2.3% to 3.5%. This top-line recovery is supported by robust underlying profitability, evidenced by impressive gross profit margins of 70.79% and an adjusted EBITDA margin of 23.1%, which also surpassed estimates. However, this positive momentum is contrasted by a substantial earnings miss, with an EPS of -$0.0048 falling well short of the $0.0128 forecast. In response, Canaccord Genuity lowered its price target to $1.50 while maintaining a 'Hold' rating, citing anticipated near-term margin pressure as management increases investments for its brand and operational transformation. The firm acknowledges the encouraging early signs of a turnaround but remains cautious due to execution risks, macroeconomic headwinds, and uncertainty around second-half shipment timing. The market appears to be weighing the positive revenue signal heavily, with the stock gaining over 9% in the past week, reflecting a cautiously optimistic sentiment around the nascent recovery.

Key Decisions for Investors

• Investors should weigh the positive signal of the first revenue growth in nine quarters against the significant EPS miss and analyst caution regarding near-term margin pressure from strategic investments.
• Monitor future earnings reports closely for evidence that the company's three-part strategy can translate top-line momentum into sustainable profitability, which is the key variable for long-term value creation.
• Given the stock is trading near Canaccord's revised $1.50 price target and the acknowledged volatility, a 'Hold' stance may be prudent until there is clearer evidence of both consistent sales growth and margin stabilization.